A little known pathVol. 2 No. 1 (2022)
In search of what is little known, from the aspects of mental health to how the deadliest viruses that humanity has faced act. The issue will focus on the capacity and choices we can make in the face of a clinical picture or confirmed diagnosis. In this issue, the new articles aim to improve understanding of how a real illness can require medical attention and, at times, the submission of knowledge from biochemistry, neuroscience and psychiatry.
Between science and religionVol. 3 No. 2 (2023)
Over the centuries, the relationship between science and religion has ranged from conflict and hostility to harmony and collaboration, while various thinkers have argued that the two concepts are inherently opposed and totally separate. "Pew Research Center"
This series contains special articles extracted for public debates. Each article offers a 'state of play perspective regarding the area of dialogue between science and religion considered, looking at both the current situation and likely future developments in this area. They aim to present the fruits of current research in specific areas to the wider scientific and religious community and the general public.
If you are a stakeholder in the scientific community or clergy and wish to comment on one of these articles specifically, please send your text directly to firstname.lastname@example.org for our review and future publication, putting your identification credentials and relationship to the institution of origin.
A leap into knowledgeVol. 1 No. 1 (2021)
What can we expect from this new Biofarma issue, if not in the sense that the articles have been selected to bring an approach to the evolution of knowledge, from cognitive sciences and experimental psychology to earth sciences, biology, and philosophy? The expected result will be a better understanding of the structural changes in the systems that affect us every day.
History almost repeats itselfVol. 3 No. 1 (2023)
Science is a perceived replication and yet, contrary to logic, the magnitude of the underlying effect size for a given experiment they always repeat.
Current and promising treatment trends and scientific validityVol. 3 No. 3 (2023)
This Biofarma volume addresses the growing field of biotechnology, medical sciences, and wellness, where the most important driving forces in the development of new treatments for mental health disorders are advancing exponentially. The biotechnology market was valued at US$1.37 trillion in 2022 and is expected to grow at a CAGR of 13.96% from 2023 to 2030. We are faced with innovative ways of dealing with the mental disorders and illnesses of the century such as anxiety, and depression, and less common disorders such as schizophrenia and psychosis, as well as the Covid-19 outbreaks that have contributed to people's emotional distress.